Neurocrine Biosciences, Inc. (NBIX) vs Repligen Corporation (RGEN)
Detailed comparison between Neurocrine Biosciences, Inc., Repligen Corporation.Total Return (%)
Neurocrine Biosciences, Inc. (NBIX)Repligen Corporation (RGEN)
Which stock do you think will perform better?
Neurocrine Biosciences, Inc.
NBIX
Repligen Corporation
RGEN
| Metric | Neurocrine Biosciences, Inc. (NBIX) | Repligen Corporation (RGEN) |
|---|---|---|
| Current Price | $94.89 | $131.54 |
| Change | 4.02 (4.42%) | 4.92 (3.89%) |
| Market Cap | $9.39B | $7.39B |
| Trailing P/E | 28.84 | 0.00 |
| Forward P/E | 15.28 | 73.90 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $157.98 | $182.52 |
| 52-Week Low | $84.23 | $102.97 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $3.29 | $-0.46 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NBIX | -15.22% | -34.95% | -29.01% | -2.18% | 117.34% | 117.74% |
| RGEN | -6.06% | -21.67% | -16.47% | 26.20% | 300.30% | 307.24% |